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ABSTRACT
O bjective : To estimate the relationship between 
maternal serum a- fetoprotein (MSAFP) levels 
and uterine artery Doppler findings at 20th week 
of pregnancy for prediction of preeclampsia and 
intrauterine growth retardation (IUGR).
M ethods: Eighty pregnant women were followed 
as a study group prospectively. MSAFP levels at 
the 15-18th week of gestation and bilateral 
uterine artery Doppler findings at the 20th week of 
gestation were obtained.
R e su lts : Bilateral early diastolic notch of the 
uterine artery was detected in 17 cases (21, 75%) 
at the 20th week of gestation. In 9 of them early 
diastolic notch was persistent at the 24th week 
while in 8 cases, it had disappeared. Uterine 
artery diastolic notch was found to be a significant 
predictive factor for preeclampsia, as well as for 
IUGR (p< 0.001, OR: 69.74; p<0.02, OR: 10.11, 
respectively). MSAFP levels of 17 cases that 
showed early diastolic notch in uterine artery 
Doppler were significantly higher than in the notch 
negative cases (p<0.05). The levels of MSAFP in 
9 cases which demonstrated the persistence of 
diastolic notch, were significantly higher than the 
8 cases where the notch had disappeared, at the 
24th week of gestation (p<0.05).
C o n c lus io n : Our findings suggest that abnormal 
uterine artery Doppler findings at 20th week of 
gestation correlate with elevated MSAFP levels, 
and bilateral diastolic notch in uterine artery at 20 
weeks’ gestation together with elevated MSAFP, 
is associated with poor obstetric outcome.
Key Words: IUGR, Preeclampsia, MSAFP, 
Diastolic notch
INTRODUCTION
Maternal serum a- fetoprotein (MSAFP) 
evaluation was first used as a screening test for 
foetal neural tube defects and detection of 
trisomy 21 (1). Once the gestational age is 
accurately determined in the second trimester, 
unexplained elevation of MSAFP higher than 2.5 
MoM (Multiples of Median) is associated with 
increased risk of preeclampsia, intrauterine 
growth retardation or pre-term labor when 
multiple pregnancies and foetal anomalies are 
excluded (2-4).On the other hand, there is a 
distinct relationship between the presence of 
early uterine artery diastolic notch and 
preeclampsia as well as adverse obstetric 
outcome (5,6).
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There are studies in the literature demonstrating 
that in cases with no foetal anomaly, at 18-22 
weeks’ gestation, there is a correlation between 
diastolic notch, abnormal uterine artery Doppler 
findings and high MSAFP level (2, 3, 7). Reports 
studying the relationship between Doppler 
findings and MSAFP level consider 2.5 MoM as a 
cut-off point.
Plowever there is a wide range of normal MSAFP 
level (0.70-2.5 MoM), higher in foetal neural tube 
defects and lower in trisomy 21 (1). As a second 
trimester screening test, the correlation between 
normal MSAFP levels and abnormal uterine 
artery Doppler findings and their relation to 
gestational prognosis are not known yet.
Our study was designed to investigate the 
relationship between the MSAFP levels below
2.5 MoM and abnormal uterine artery Doppler 
findings with gestational prognosis. The 
relationship between uterine artery Doppler 
findings, early diastolic notch and MSAFP levels 
at the18-20th gestational weeks, and their 
predictive value for preeclampsia and 
intrauterine growth retardation were investigated.
MATERIALS AND METHODS
This prospective, randomized study included 80 
non-smoking pregnant women who were 
followed-up during the antenatal period and 
delivered by the perinatology unit of the 
Obstetrics and Gynaecology Department during 
the period 1998-2000. Cases with foetal 
anomaly, diabetes and multiple pregnancies 
were excluded from the study group. The 
patients were chosen among the 1400 women 
who attended perinatology clinics.
The patients in the antenatal follow-up protocol 
were screened with biochemical-screening tests 
(Down Screening Test) during 15-18th gestational 
weeks and maternal serum a-fetoprotein, 
unconjugated estriol and (3-hCG levels were 
obtained.
The a- fetoprotein levels were determined by 
radioimmunoassay kits (Amerlex-M second 
trimester AFP RIA Kit) by “Ortho- Clinical 
Diagnostic Amersham, U.K.”. In evaluating the 
results a computer program ‘Prenatal Interpretive
Software’ developed by Robert Maciel 
Associates was used. Therefore, the corrected 
levels of MoM for each gestational week, were 
obtained using the median levels for Turkish 
women and also taking into account factors like 
weight and smoking.
Between 18-20 gestational weeks, while 
ultrasonographic screening for anomalies was 
performed, double-sided uterine artery Doppler 
examination was also done. Pulsed color 
Doppler ultrasonography was performed 
transabdominally by an “HDL 3000” 
ultrasonography machine using a 3.5 MHz probe.
In the waveform; early diastolic notch, PI 
(Pulsatility Index), Rl (Resistance Index) and S/D 
(Systolic / Diastolic ratio) measurements were 
taken. End systolic or early diastolic notch form 
was described as a notch as described in the 
literature (5). Patients who were bilaterally notch 
positive at 20th gestational week were examined 
again at 24th gestational week to see whether this 
persisted.
As preeclampsia criteria, arterial blood pressure 
higher than 140/90 mmHg after 24th gestational 
week and/or proteinuria higher than 300 mg/day 
was accepted (8). The intrauterine growth 
retardation, the foetal weight during follow-up 
and neonatal weight after birth had to be lower 
than 10% percentile (1).
On Doppler examination, the correlation between 
bilateral diastolic notch and preeclampsia and 
intrauterine growth retardation was searched. 
When an early diastolic notch was detected, 
increased risks for preeclampsia and intra­
uterine growth retardation were investigated 
using the Fisher's test.
On 20th week of gestation, the MSAFP levels 
belonging to cases which are notch (+) and notch 
(-) in uterine diastolic artery Doppler were 
compared. Subsequently, MSAFP levels of 
diastolic notch positive 9 patients and 8 notch 
negative patients at 24th gestational week were 
evaluated by Student’s t test.
In our study group, MSAFP levels in cases with 
preeclampsia and intrauterine growth retardation 
were compared with those cases without these 
complications using Student’s t test. The
1 7 0
M a te rn a l s e ru m  A F P  a n d  fe ta l p ro g n o s is
relationship between normal accepted MSAFP 
levels and poor gestational outcome was 
searched for by this method. The statistical 
evaluations were carried out by ‘Unistat for 
Windows 5.0’ program.
RESULTS
Of 80 cases participating in our study, the 
majority was younger than 35 years and the 
mean age was 30.85 + 6.11 (19-44). In this 
group, preeclampsia and IUGR were found in 
12.5% and 11.25% respectively. Parity, risk 
factors for pregnancy characteristics are 
presented in table I. Pregnant women with 
chronic hypertension and autoimmune diseases 
did not have significantly different MSAFP levels 
compared to pregnant women without risk factors 
(p>0.05).
T a b le  I: Patient characteristics.
(N=80) %
Maternal age <35 59 73,75
Maternal age >35 21 26.25
Nulliparity 36 45
Multiparity (1-4) 44 55
Risk factor (-) 45 56,25
Risk factor (+) ■ 35 43,75
Hypertension and PE' 15 18,75
Autoimmune dis. 8 10
Gestational DM" 6 7,5
Triple test (+) 6 7,5
‘ PE = Preeclampsia.
“  DM= Diabetes Mellitus
T a b le  II: The relationship between the, ’d ia s to l ic  n o tc h ,’ in 
the uterine artery at the 20th weeks of pregnancy 
and pregnancy outcome.
Notch (+) Notch (-) P OR
PE (N: 10)* 9 1 p<0.001 69,74
IUGR (N:9)** 6 3 p<0.02 10.11
■ PE = Preeclampsia.
* ' IUGR = Intrauterine growth retardation
With respect to maternal a- fetoprotein and 
Doppler relationship in bilateral diastolic notch (+) 
cases, 17 notch positive cases were found to 
have a significant increase in MSAFP levels. The 
difference with normal a- fetoprotein levels in 63 
cases that were notch (-) was statistically 
significant (p<0.05) (Table III).
T a b le  III: The relationship between “diastolic notch” in the 
uterine artery Doppler and the level of MSAFP
Notch (+) Notch (-) P
N = 17 N = 63
MSAFP*
(MoM)** 1,33±0,61 0,97±0,32 <.05
* MSAFP = Maternal Serum (¿-Fetoprotein 
* * MoM = Multiples of Median
Of 17 cases with bilateral diastolic notch (+), the 
levels of MSAFP in 9 persisting and 8 non­
persisting patients at 24 weeks' were compared 
and the MSAFP levels were significantly higher in 
notch positive patients at both 20 and 24 
gestational weeks (p<0.05) (Table IV).
Uterine artery Doppler waveform displayed 
double-sided early diastolic notch in 21.25% 
(17/80) of the cases. In 17 cases with diastolic 
notch during 18-20 gestational weeks, it 
persisted in 9 patients and disappeared in 8 
patients. Cases with unilateral notching during 
18-20 weeks or in the 24 weeks cut-off period 
were not included in the study.
In the overall study population, the median 
MSAFP level was determined as 1.07+ 0.43 
MoM (0,38-2.24) in the triple test at 15-18 
gestational weeks. The presence of bilateral 
diastolic notch in uterine artery Doppler was a 
significant indicator of preeclampsia and 
intrauterine growth retardation (p<0.02 and 
p<0.002 respectively) (Table II).
T a b le  IV: MSAFP levels in the case of positive and 
persistent notch at both 20,h and 24m weeks of 
pregnancy and in the case of lost notch during 
24th week of pregnancy (total 17 cases)
24. GH Notch (+) 
N = 9
24. GH Notch (-) 
N = 8
P
MSAFP*
(MoM)** 1,68+0,46 0.94±0,65 <.05
* MSAFP = Maternal Serum «-Fetoprotein 
"MoM = Multiples of Median
The MSAFP levels in patients with preeclampsia 
and intrauterine growth retardation were higher 
than pregnant women who did not show these 
complications. This increase was significant at 
p<0.01 levels in women with preeclampsia and 
intrauterine growth retardation (Table V).
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T a b le  V: In c re ase  in th e  level of M SA FP in th e  c a s e s  of PE  
an d  IUGR in co m p ariso n  with norm al p reg n an cy .
N MSAFP (MoM)
PE (+)** 10 1,65 ±0,53"
PE (-) 70 0,97 ±0,34
IUGR (+)*** 9 1,86 ± 0,30"
IUGR (-) 71 0.95 ± 0.34
* P <. .001
•• PE = Preeclampsia
"• IUGR = Intra Uterine Growth Retardation
DISCUSSION
Maternal serum a - fetoprotein levels (MSAFP) 
are determined as part of the antenatal follow-up 
protocol in “Down screening test” and for 
screening neural tube defects (1).
In the previous studies, high maternal serum a - 
fetoprotein levels of 2,5 MoM or higher, recorded 
In the second trimester, Indicate Increased risks 
of preeclampsia, Intrauterine growth retardation, 
pre-term labor and placental abruption other than 
foetal anomalies and multiple pregnancies (7- 
10).
Although the incidence of preeclampsia Is cited 
to be about 5 percent it can complicate up to 15% 
of pregnancies and the percentage of IUGR Is 
estimated 10% when the infants whose weights 
are below the 10th percentile for their gestational 
age were accepted as growth restricted. In our 
study the incidence of pre-cclampsia and IUGR 
was 12.5% and 11.25% respectively. Our 
incidence rate was high because the population 
was consisting of women with high rik pregnancy.
In 36% of pregnancies with high MSAFP levels 
without a distinct reason, there is at least one 
etiologic cause for adverse pregnancy outcome. 
The most important factors of poor prognosis are 
preeclampsia, intrauterine growth retardation and 
pre-term labour. In case the MSAFP levels are
2.5 MoM or higher, the risks of the gestational 
complications increase 2-11 times (7).
During pregnancy, starting with implantation, 
there are physiological changes, which increase 
the blood flow in the intervillous space and 
decrease the blood pressure in the uterine
arteries. These changes consist of the 
trophoblastic vascular invasion of spiral arteries 
extending from the myometrium to the decidua in 
the first and second trimesters and their 
transformation to utero-placental arteries (5, 11). 
In preeclampsia and intrauterine growth 
retardation, these physiological changes, which 
should occur during placentation, are absent or 
are insufficient (6, 8). The absence or the 
inadequacy of these physiological changes is 
due to deciduas and/or trophoblastic functional 
disturbances. In Doppler studies, early diastolic 
notch and increase in resistance to blood flow is 
seen in the uterine artery Doppler waveform if the 
physiological changes are incomplete or absent 
(6, 12). In past studies, a significant correlation 
was found between preeclampsia and poor 
gestational prognosis with high Rl, PI and S/D 
levels, which belong to Doppler waveforms and 
presence of early diastolic notch (5, 6).
In patients with high MSAFP levels of unknown 
cause, there is a marked increase in abnormal 
Doppler findings and presence of diastolic notch 
in the uterine artery Doppler during 18-22nd 
weeks of gestation (2,4 ,13). These Doppler 
studies are usually performed on pregnant 
women who have MSAFP levels of 2.5 MoM or 
higher.
In the second trimester biochemical-screening 
(Down screening) programme, the normal 
accepted values for MSAFP have a wide range 
as 0.70-2.5 MoM (1). There are no studies on 
whether there is a correlation between poor 
gestational prognoses and abnormal uterine 
artery Doppler findings with these values and 
between which MSAFP levels are present. For 
this reason, our study group consisted of 
pregnant women with normal MSAFP levels less 
than 2.5 MoM. The current literature points out 
that the diastolic notch in the uterine artery during 
the 18-24th gestational weeks is an important 
indication for determining preeclampsia and 
intra-uterine growth retardation (6, 14). In 
21.25% of our patients, two-sided diastolic notch 
was observed.
The abnormal Doppler findings in our group were 
higher compared with the pregnant population 
without risk factors. This may be due to the 
various risk factors of our pregnant group (Table 
I). In this group, the diastolic notch in the uterine
1 7 2
M a te rn a l s e ru m  A F P  a n d  le ta l  p ro g n o s is
artery Doppler during 18-20,h gestational weeks 
indicates an increase in preeclampsia and 
intrauterine growth retardation, which correlates 
with current literature citing.
The sensitivity of the diastolic notch in indicating 
poor gestational prognosis is high for 
preeclampsia and intra-uterine growth 
retardation. Although, it is also significant for 
detection of pre-term labour, the odds ratio 
decreases (Table II).In patients with diastolic 
notch in their uterine artery Doppler, the MSAFP 
levels are higher than in those with normal 
findings (Table III).
On the other hand, the diastolic notch found in 17 
of the cases during 20th gestational week 
disappeared in 8 cases at the 24th gestational 
week. Only one of the 8 patients whose diastolic 
notch disappeared in the 24th gestational week 
had preeclampsia. These findings point to the 
fact that the diastolic notch determined in the 20th 
gestational week is less sensitive than that 
determined during the 24th gestational week in 
showing poor prognosis. When the physiological 
changes are considered, this result is not 
surprising. The current literature also supports 
this finding (5,11,12). In normal pregnancies, 
trophoblastic invasion of utero-placental arteries 
is completed at 20-22nd gestational weeks (5,6). 
According to our results, 9 patients who were 
diastolic notch positive in uterine artery Doppler 
in 20th week of gestation, persisting until the 24,h 
week, had considerably high levels of MSAFP 
(Table IV).
This shows that at 20th week of gestation, 
Doppler findings evaluated together with MSAFP 
levels are an indicator of poor prognosis and 
does not necessitate waiting for the 24th 
gestational week. Diastolic notch and poor 
gestational outcome may be due to the 
insufficient trophoblastic invasion of the utero­
placental arterial endothelium ahd its damage, 
causing increase in transmission of foetal AFP to 
the maternal side. The results of our study 
support these conclusions. Mean MSAFP level of 
patients with abnormal Doppler results and 
adverse pregnancy outcome was 1.5 MoM or 
higher. On the other hand, in this group, patients 
with preeclampsia and intrauterine growth 
retardation had higher MSAFP values compared 
with uncomplicated cases (Table V).
Double-sided diastolic notch determined in the 
uterine artery Doppler at 20 weeks' gestation is a 
significant indicator of preeclampsia and intra­
uterine growth retardation. In the presence of the 
notch, there is an increased risk of these 
disturbances.
In patients whose uterine artery Doppler showed 
diastolic notch or abnormal findings, the MSAFP 
levels were significantly high even if they were 
within normal ranges. In other cases where the 
diastolic notch was determined at 20 weeks' 
gestation and persisted until 24 weeks, the 
MSAFP levels increased significantly in 
comparison with those whose diastolic notch 
disappeared.
Also in patients with preeclampsia and 
intrauterine growth retardation, the MSAFP 
levels were higher in comparison with those who 
had good prognosis.
Our study shows that abnormal uterine artery 
Doppler findings and high levels of MSAFP at 20 
weeks’ gestation coexist in high-risk 
pregnancies.
Depending on these data, it is concluded that the 
abnormal uterine artery Doppler findings, when 
evaluated with MSAFP levels will be more 
sensitive in determining poor pregnancy 
outcome. This hypothesis should be supported 
by further studies carried out with more patients.
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